{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:02:29Z","timestamp":1789603349755,"version":"build-2803163510"},"publisher-location":"New York, NY","reference-count":21,"publisher":"Springer New York","isbn-type":[{"value":"9781493933853","type":"print"},{"value":"9781493933877","type":"electronic"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/978-1-4939-3387-7_7","type":"book-chapter","created":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T11:08:16Z","timestamp":1460632096000},"page":"155-166","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Development of Rabies Virus-Like Particles for Vaccine Applications: Production, Characterization, and Protection Studies"],"prefix":"10.1007","author":[{"given":"Diego","family":"Fontana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Etcheverrigaray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Kratje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Prieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,14]]},"reference":[{"key":"7_CR1","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1743-422X-9-50","volume":"9","author":"MZ Yousaf","year":"2012","unstructured":"Yousaf MZ, Qasim M, Zia S, Khan MR, Ashfaq UA, Khan S (2012) Rabies molecular virology, diagnosis, prevention and treatment. Virol J 9:50","journal-title":"Virol J"},{"key":"7_CR2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrmicro2260","volume":"8","author":"MJ Schnell","year":"2010","unstructured":"Schnell MJ, McGettigan JP, Wirblich C, Papaneri A (2010) The cell biology of rabies virus: using stealth to reach the brain. Nat Rev Microbiol 8:51\u201361","journal-title":"Nat Rev Microbiol"},{"key":"7_CR3","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.vaccine.2011.11.007","volume":"30","author":"P Gautret","year":"2012","unstructured":"Gautret P, Parola P (2012) Rabies vaccination for international travelers. Vaccine 30:126\u2013133","journal-title":"Vaccine"},{"key":"7_CR4","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.antiviral.2013.03.011","volume":"98","author":"FX Meslin","year":"2013","unstructured":"Meslin FX, Briggs DJ (2013) Eliminating canine rabies, the principal source of human infection: what will it take? Antivir Res 98:291\u2013296","journal-title":"Antivir Res"},{"key":"7_CR5","unstructured":"World Health Organization (2013). WHO expert consultation on rabies. Second report. World Health Organ Tech Rep Ser 982"},{"issue":"9","key":"7_CR6","doi-asserted-by":"publisher","first-page":"e515","DOI":"10.1371\/journal.pntd.0000515","volume":"3","author":"HC Ertl","year":"2009","unstructured":"Ertl HC (2009) Novel vaccines to human rabies. PLoS Negl Trop Dis 3(9):e515","journal-title":"PLoS Negl Trop Dis"},{"key":"7_CR7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.7774\/cevr.2013.2.1.19","volume":"2","author":"DK Yang","year":"2013","unstructured":"Yang DK, Kim HH, Lee KW, Song JY (2013) The present and future of rabies vaccine in animals. Clin Exp Vaccine Res 2:19\u201325","journal-title":"Clin Exp Vaccine Res"},{"key":"7_CR8","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/S0966-842X(03)00208-7","volume":"11","author":"R Noad","year":"2003","unstructured":"Noad R, Roy P (2003) Virus-like particles as immunogens. Trends Microbiol 11:438\u2013444","journal-title":"Trends Microbiol"},{"issue":"10","key":"7_CR9","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1586\/erv.10.115","volume":"9","author":"A Rold\u00e3o","year":"2010","unstructured":"Rold\u00e3o A, Mellado MCM, Castilho LR, Carrondo MJT, Alves PM (2010) Virus-like particles in vaccine development. Expert Rev Vaccines 9(10):1149\u20131176","journal-title":"Expert Rev Vaccines"},{"key":"7_CR10","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/bit.25159","volume":"111","author":"LHL Lua","year":"2014","unstructured":"Lua LHL, Connors NK, Sainsbury F, Chuan YP, Wibowo N, Middelberg APJ (2014) Bioengineering virus-like particles as vaccines. Biotechnol Bioeng 111:425\u2013440","journal-title":"Biotechnol Bioeng"},{"key":"7_CR11","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1016\/j.vaccine.2014.02.031","volume":"32","author":"D Fontana","year":"2014","unstructured":"Fontana D, Kratje R, Etcheverrigaray M, Prieto C (2014) Rabies virus-like particles expressed in HEK293 cells. Vaccine 32:2799\u20132804","journal-title":"Vaccine"},{"issue":"3","key":"7_CR12","doi-asserted-by":"publisher","first-page":"e784","DOI":"10.1371\/journal.pone.0009784","volume":"5","author":"CY Wu","year":"2010","unstructured":"Wu CY, YehYC YYC, Chou C, Liu MT, Wu HS, Chan JT, Hsiao PW (2010) Mammalian expression of virus-like particles for advanced mimicry of authentic influenza virus. Plos One 5(3):e784","journal-title":"Plos One"},{"key":"7_CR13","doi-asserted-by":"publisher","first-page":"4294","DOI":"10.1016\/j.vaccine.2010.04.025","volume":"28","author":"C Chuan Li","year":"2010","unstructured":"Chuan Li C, Liu F, Liang M, Zhang Q, Wang X, Wang T, Li J, Li D (2010) Hantavirus-like particles generated in CHO cells induce specific immune responses in C57BL\/6 mice. Vaccine 28:4294\u20134300","journal-title":"Vaccine"},{"key":"7_CR14","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1472-6750-14-62","volume":"14","author":"RH Hua","year":"2014","unstructured":"Hua RH, Li YN, Chen ZS, Liu LK et al (2014) Generation and characterization of a new mammalian cell line continuously expressing virus-like particles of Japanese encephalitis virus for a subunit vaccine candidate. BMC Biotechnol 14:62","journal-title":"BMC Biotechnol"},{"key":"7_CR15","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1128\/JVI.72.11.8463-8471.1998","volume":"72","author":"T Dull","year":"1998","unstructured":"Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D, Naldini L (1998) A third-generation lentivirus vector with a conditional packaging system. J Virol 72:8463\u20138471","journal-title":"J Virol"},{"key":"7_CR16","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1126\/science.272.5259.263","volume":"272","author":"L Naldini","year":"1996","unstructured":"Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH et al (1996) In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263\u2013267","journal-title":"Science"},{"issue":"5","key":"7_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1517\/13543776.18.5.525","volume":"18","author":"V Pican\u00e7o-Castro","year":"2008","unstructured":"Pican\u00e7o-Castro V, Fontes AM, de Sousa Russo-Carbolante EM, Covas DR (2008) Lentiviral-mediated gene transfer \u2013 a patent review. Expert Opin Ther Pat 18(5):1\u201315","journal-title":"Expert Opin Ther Pat"},{"key":"7_CR18","doi-asserted-by":"crossref","unstructured":"Federico M (ed) (2010) Lentivirus gene engineering protocols. 2nd edition. Methods in Molecular Biology , Vol. 614. Humana, UK","DOI":"10.1007\/978-1-60761-533-0"},{"key":"7_CR19","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s12033-012-9598-4","volume":"53","author":"A Zeltins","year":"2012","unstructured":"Zeltins A (2012) Construction and characterization of virus-like particles: a review. Mol Biotechnol 53:92\u2013107","journal-title":"Mol Biotechnol"},{"key":"7_CR20","first-page":"360","volume-title":"Laboratory techniques in rabies","author":"LA Wilbur","year":"1996","unstructured":"Wilbur LA, Aubert MFA (1996) The NIH potency test. In: Meslin FX, Kaplan MM, Koprowsky H (eds) Laboratory techniques in rabies. WHO, Geneva, Switzerland, pp 360\u2013366"},{"issue":"8","key":"7_CR21","doi-asserted-by":"publisher","first-page":"P7","DOI":"10.1186\/1753-6561-5-S8-P7","volume":"5","author":"C Prieto","year":"2011","unstructured":"Prieto C, Fontana D, Etcheverrigaray M, Kratje R (2011) A strategy to obtain recombinant cell lines with high expression levels. Lentiviral vector-mediated transgenesis. BMC Proc 5(8):P7","journal-title":"BMC Proc"}],"container-title":["Methods in Molecular Biology","Vaccine Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-3387-7_7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T17:24:39Z","timestamp":1600449879000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-3387-7_7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9781493933853","9781493933877"],"references-count":21,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-3387-7_7","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]},"assertion":[{"value":"14 April 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}